BMO cuts Avery Dennison stock price target on estimate tweak By Investing.com

Avery Dennison reported first-quarter EPS of $2.47 versus $2.43 expected and revenue of $2.3 billion versus $2.26 billion expected, but BMO Capital still cut its price target to $213 from $222 while keeping an Outperform rating. The firm called second-quarter guidance conservative, though it expects intelligent labels growth to accelerate in the second half and cited free cash flow, balance sheet strength, and valuation support. Shares trade at $163.37, just above the 52-week low of $156.23, while the company continues a 15-year dividend ზრდa track record.

Analysis

The market is still pricing AVY like a slow-cycle packaging/label name, but the setup is more asymmetric than that. The key second-order effect is that management appears to have already cleared the worst of the cost and pricing reset, which means incremental operating leverage can reassert faster than consensus models usually capture once volume stabilizes and mix shifts toward intelligent labels. If the second-half acceleration in higher-margin smart-labels materializes, the earnings inflection could be more about mix than top-line growth, which tends to support multiple expansion even in a soft industrial tape.

What matters most near-term is not the headline beat but the durability of guidance conservatism. If the company is intentionally underpromising, the stock can re-rate over the next 1-2 quarters on estimate revisions alone; if not, this remains a value trap risk because the stock is already close to its cycle low and sentiment is fragile. The balance sheet and dividend support downside, but they do not protect against another de-rating if apparel/end-market demand weakens or if intelligent labels growth slips another quarter.

Consensus is missing that this is increasingly a quality-versus-cyclicals relative value setup, not just a standalone turnaround. Suppliers and peers exposed to lower-value labeling and commodity-sensitive packaging may face margin compression if AVY’s pricing discipline holds, while AVY’s higher-tech mix can earn a scarcity premium if execution stays clean. The strongest catalyst window is the next two earnings prints: one for evidence of mix improvement, and the following one for whether that improvement is broad-based or just inventory normalization.

Key Decisions for Investors

• Go long AVY on weakness near the lower end of its recent range; use a 3-6 month horizon with a target toward the low-$200s if second-half mix improvement shows up in estimates. Risk/reward is attractive if downside is limited by cash flow and dividend support, but cut if management misses on margin expansion again.
• Pair trade: long AVY / short a lower-quality packaging or label peer with higher leverage to commodity inputs and weaker margin structure over the next 1-2 quarters. The thesis is relative multiple expansion in AVY as earnings quality improves while the short is exposed to more estimate compression.
• Buy AVY Jan-2026 call spreads to express a second-half acceleration view with defined risk. Favor strikes that monetize a move into the $190-$210 area; this is best if you expect the market to re-rate on one or two clean prints rather than immediate upside.
• If already long, hedge with a short-dated covered call against near-term event risk into the next earnings cycle. The stock can grind higher, but near-term execution risk is still high enough that premium collection is preferable to naked upside exposure.
• Set a trigger to add only if management confirms intelligent labels acceleration or raises guidance language next quarter; absent that, the stock should be treated as a balance-sheet-supported value name, not a high-conviction growth rerating.